Levy D, et al.: Principal results of the hypertension and lipid trial (HALT); a multicenter study of doxazosin in patients with hypertension. Am Heart J 131: 966-973, 1996
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group: Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension 42: 239-246, 2003
Chapman N, et al.: Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian Cardiac Outcomes Trial. Circulation 118: 42-48.2008